Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Read Article
News
2024
2023
Archive
Search news articles
January 22, 2024
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
January 22, 2024
Dianthus Therapeutics Announces $230 Million Private Placement
January 18, 2024
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
January 9, 2024
Skye Bioscience Receives IND Clearance for Phase 2 Clinical Trial of Nimacimab in Obesity and Chronic Kidney Disease
January 5, 2024
GlycoEra AG Announces New Investor, Appoints Industry Veteran Greg Fralish as Chief Business Officer
January 4, 2024
Radionetics Oncology Raises $52.5 Million Series A to Advance First-in-Class Radiopharmaceutical Pipeline and Announces the Appointment of Industry Leader, Paul Grayson, as CEO
December 20, 2023
Rallybio Announces Preliminary Phase 1 Multiple Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5
December 18, 2023
TMRW Life Sciences Expands Globally Entering UK Fertility Market
December 8, 2023
Kinaset Therapeutics to Present KN-002 Phase 1 Clinical Study Outcomes at the 2024 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting
December 8, 2023
Cidara Therapeutics Presents New Promising Preclincal Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress
« Previous Page
1
2
3
4
5
…
118
Next Page »